thioridazine has been researched along with Protein Aggregation, Pathological in 1 studies
Thioridazine: A phenothiazine antipsychotic used in the management of PHYCOSES, including SCHIZOPHRENIA.
thioridazine : A phenothiazine derivative having a methylsulfanyl subsitituent at the 2-position and a (1-methylpiperidin-2-yl)ethyl] group at the N-10 position.
Protein Aggregation, Pathological: A biochemical phenomenon in which misfolded proteins aggregate either intra- or extracellularly. Triggered by factors such as MUTATION; POST-TRANSLATIONAL MODIFICATIONS, and environmental stress, it is generally associated with ALZHEIMER DISEASE; PARKINSON DISEASE; HUNTINGTON DISEASE; and TYPE 2 DIABETES MELLITUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cragnaz, L | 1 |
| Spinelli, G | 1 |
| De Conti, L | 1 |
| Bureau, EA | 1 |
| Brownlees, J | 1 |
| Feiguin, F | 1 |
| Romano, V | 1 |
| Skoko, N | 1 |
| Klima, R | 1 |
| Kettleborough, CA | 1 |
| Baralle, FE | 1 |
| Baralle, M | 1 |
1 other study available for thioridazine and Protein Aggregation, Pathological
| Article | Year |
|---|---|
Thioridazine reverts the phenotype in cellular and Drosophila models of amyotrophic lateral sclerosis by enhancing TDP-43 aggregate clearance.
Topics: Amyotrophic Lateral Sclerosis; Animals; Autophagy; Cell Line; Disease Models, Animal; DNA-Binding Pr | 2021 |